OM:BINVBiotechs
BioInvent International Q4 Losses Undercut Bullish Profitability Narrative Despite Strong Q2 Profit
BioInvent International (OM:BINV) has wrapped up FY 2025 with fourth quarter revenue of 3.016 million SEK and a basic EPS loss of 1.91 SEK, while trailing twelve month figures show revenue of 226.495 million SEK and a basic EPS loss of 5.06 SEK. Over recent quarters, the company has seen revenue move from 21.369 million SEK in Q4 2024 to 22.06 million SEK in Q1 2025, 198.098 million SEK in Q2 2025, and 3.321 million SEK in Q3 2025, alongside quarterly basic EPS figures ranging from a 1.48 SEK...